Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study.

199781 citationsJournal Article

Authors

Howard Safran · Brown University

TA King

Abstract

Concurrent paclitaxel with upper abdominal RT is well tolerated at dosages that have substantial activity. A phase II trial of neoadjuvant paclitaxel and RT at the MTD of 50 mg/m2/wk is underway.

Topics & Keywords

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 15, Issue 3, pp. 901-907

DOI: 10.1200/jco.1997.15.3.901

Field-Weighted Citation Impact: 4.13